Hahn stress­es im­por­tance of da­ta, RWE in first all-hands meet­ing

FDA Com­mis­sion­er Stephen Hahn ad­dressed FDA staffers in an all-hands meet­ing for the first time on Thurs­day, ex­plain­ing how he wants to do more with re­al-world ev­i­dence (RWE), which has been a con­tro­ver­sial sub­ject.

While not­ing that the FDA is op­er­at­ing in a time of “un­sur­passed sci­en­tif­ic and tech­no­log­i­cal in­no­va­tion,” Hahn called to un­leash the pow­er of da­ta and “to at­tain more and bet­ter da­ta.” His com­ments build up­on the agency’s tech­nol­o­gy mod­ern­iza­tion plan un­veiled last Sep­tem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER